PMID- 10732294 OWN - NLM STAT- MEDLINE DCOM- 20000411 LR - 20181113 IS - 0169-4197 (Print) IS - 0169-4197 (Linking) VI - 26 IP - 3 DP - 1999 Dec TI - Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer. PG - 173-9 AB - BACKGROUND: The interaction between immunocompetent cells and tumor endothelium is essential for an effective immunological response. In the present study, we evaluated resting and CD11b/CD18-mediated leukocyte adhesion in tumor vessels of experimental pancreatic cancer and in healthy pancreatic venules in the rat. METHODS: Solid tumor fragments (1 mm3) were interposed intrapancreatically between inert transparent polymethylmetacrylate plates for intravital microscopy (n = 12) by which tumor microcirculation, leukocyte-tumor-endothelium interaction, and the effect of the chemoattractants N-formyl-methioninleucylphenylalanine (fMLP) and platelet-activating factor (PAF) on leukocyte adherence was investigated. RESULTS: Leukocyte adhesion in pancreatic tumor vessels was significantly reduced compared to healthy pancreatic venules. Both fMLP and PAF dramatically increased leukocyte adherence in normal pancreatic venules. No change in leukocyte adhesion was present in tumor vessels after exposure to these chemotactic substances. CONCLUSION: Resting and stimulated integrin-dependent leukocyte adhesion is strongly reduced in malignant vessels of experimental pancreatic cancer, which may be an important mechanism to escape immune control. FAU - Schmidt, J AU - Schmidt J AD - Department of Surgery, University of Heidelberg, Germany. FAU - Ryschich, E AU - Ryschich E FAU - Maksan, S M AU - Maksan SM FAU - Werner, J AU - Werner J FAU - Gebhard, M M AU - Gebhard MM FAU - Herfarth, C AU - Herfarth C FAU - Klar, E AU - Klar E LA - eng PT - Journal Article PL - United States TA - Int J Pancreatol JT - International journal of pancreatology : official journal of the International Association of Pancreatology JID - 8703511 RN - 0 (Chemotactic Factors) RN - 0 (Platelet Activating Factor) RN - 59880-97-6 (N-Formylmethionine Leucyl-Phenylalanine) SB - IM MH - Animals MH - Blood Flow Velocity MH - Blood Vessels/metabolism MH - Carcinoma/blood supply/*pathology/*physiopathology MH - Cell Adhesion/drug effects/physiology MH - Chemotactic Factors/pharmacology MH - Endothelium/*physiopathology MH - Endothelium, Vascular/physiopathology MH - Erythrocytes/physiology MH - Leukocytes/*physiology MH - Lymphocyte Culture Test, Mixed MH - N-Formylmethionine Leucyl-Phenylalanine/metabolism MH - Pancreatic Neoplasms/blood supply/*pathology/*physiopathology MH - Platelet Activating Factor/metabolism MH - Rats MH - Venules EDAT- 2000/03/25 09:00 MHDA- 2000/04/15 09:00 CRDT- 2000/03/25 09:00 PHST- 2000/03/25 09:00 [pubmed] PHST- 2000/04/15 09:00 [medline] PHST- 2000/03/25 09:00 [entrez] AID - 10.1385/IJGC:26:3:173 [doi] PST - ppublish SO - Int J Pancreatol. 1999 Dec;26(3):173-9. doi: 10.1385/IJGC:26:3:173.